| Abstrakt: |
The article discusses research conducted by the Russian Academy of Sciences on the design, synthesis, and structure-activity relationship studies of N-Aryl Benzimidazole and Benzotriazole derivatives and their hybrids as cytotoxic agents. The study focuses on the creation of hybrid molecules to increase therapeutic efficacy and reduce side effects in cancer treatment. The research highlights promising diphenylamine-based bipharmacophoric compounds as potential platforms for developing effective antitumor agents. For more information, readers can refer to the original article published in Molecules. [Extracted from the article] |
